Safety of ENC-201-CED ENCRT (NCT06408311)

🧪 Interventions in This Study

• ENC-201-CED hPI (COMBINATION_PRODUCT)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (2 Sites)

• UHN — Toronto, Ontario
• McGill University Health Centre — Montreal, Quebec

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Diabetes Mellitus, Type 1

• Testing an Integrated Care Model Trial — Atlanta, Georgia
• Teplizumab in Pediatric Stage 2 Type 1 Diabetes — San Francisco, California
• Allogenic Islet Cell Transplantation — Chicago, Illinois
• Cellular Therapy for Type 1 Diabetes Using Mesenchymal Stem Cells — Charleston, South Carolina
• Feasibility Study of Extended Wear Insulin Infusion Set Options During Home Use in People With Type 1 Diabetes — Stanford, California

Explore by condition: All Diabetes Mellitus, Type 1 clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Review the official NIH record below to find the coordinating site.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.